Evidence map›Paper›PMID 35833531›Full record

ArticleJournal of clinical periodontology2022

Oral characteristics in adult individuals with periodontal Ehlers-Danlos syndrome.

Ulrike Lepperdinger, Chloe Angwin, Di Milnes, Glenda Sobey, Neeti Ghali, Diana Johnson, Angela F Brady, Tammy Kammin, Jessica M Bowen, Rebekka Gröbner and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical periodontology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Genetic diagnosis of the Ehlers-Danlos syndromes.Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Ulrike LepperdingerDepartment of Operative and Restorative Dentistry, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0003-3584-7650
Chloe AngwinNational Ehlers Danlos Syndrome Service, London North West University Healthcare NHS Trust, London, UK.
Di MilnesGenetic Health Queensland, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.ORCID 0000-0001-8779-5157
Glenda SobeyEhlers Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, Sheffield, UK.
Neeti GhaliNational Ehlers Danlos Syndrome Service, London North West University Healthcare NHS Trust, London, UK.
Diana JohnsonEhlers Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, Sheffield, UK.
Angela F BradyNational Ehlers Danlos Syndrome Service, London North West University Healthcare NHS Trust, London, UK.
Tammy KamminEhlers Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, Sheffield, UK.
Jessica M BowenEhlers Danlos Syndrome National Diagnostic Service, Sheffield Children's Hospital, Sheffield, UK.
Rebekka GröbnerInstitute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Pernilla LundbergDepartment of Molecular Periodontology, Umeå University, Umeå, Sweden.ORCID 0000-0002-8244-5200
James ScottAcademic Unit of Restorative Dentistry, Sheffield University, Sheffield, UK.
Johannes ZschockeInstitute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
Fleur S van DijkNational Ehlers Danlos Syndrome Service, London North West University Healthcare NHS Trust, London, UK.
Ines Kapferer-SeebacherDepartment of Operative and Restorative Dentistry, Medical University of Innsbruck, Innsbruck, Austria.ORCID 0000-0001-6169-6812
Innsbruck Medical University · ATLondon North West Healthcare NHS Trust · GBSheffield Children's Hospital · GBRoyal Brisbane and Women's Hospital · AUUmeå University · SEUniversity of Sheffield · GB

Funding

Ehlers-Danlos Society 2019.02.PRO05
6 · The paper itself

Abstract

aimPeriodontal Ehlers-Danlos syndrome (pEDS) is a monogenic type of Ehlers-Danlos syndrome characterized by periodontal destruction at a young age. The present study aimed to document the oral phenotype of pEDS based on prospective clinical investigations. MATERIALS AND

methodsThirty-five adult individuals from 13 families with a clinically and genetically confirmed diagnosis of pEDS underwent a systematic oral assessment.

resultsPeriodontitis stage 3 or 4 or edentulism due to periodontal destruction were diagnosed in 94% of the individuals. First permanent tooth loss was reported at the age of 21.5 years (median; range 13-43 years). Deep periodontal pockets were infrequent, with 94% measuring <4 mm. However, there was increased clinical attachment loss (CAL) averaging 8 mm (range 4-13 mm), and the probability of being edentate between the age of 35 and 44 years was 28-47% compared with less than 0.25% of the general population. Radiographic anomalous findings were only found in a portion of subjects and consisted of fused roots of maxillary second molars (81%), root hypoplasia (57%), taurodontism (26%) and tooth rotation of premolars (67%). As such, radiographic findings are not considered common characteristics of pEDS.

conclusionsCharacteristic oral traits of pEDS in adults are severe CAL with shallow probing depths and marked gingival recession. This is complemented by a lack of attached gingiva. These indications need to be paralleled by genetic analyses to diagnose pEDS unambiguously.

Indexed as

Ehlers-Danlos SyndromeGingival RecessionPeriodontitisBicuspidHumansPeriodontal Attachment LossProspective Studiesattached gingivaC1RC1SEhlers-Danlos syndromeperiodontitis

Identifiers

PMID35833531
PMCPMC9796896
OpenAlexW4285495431

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.